Table 1.
Characteristic | N (%) |
---|---|
Age at diagnosis | |
Median (IQR) | 60 (53–68) |
TTS (days) | |
Median (IQR) | 33 (21–49) |
1–30 | 16 957 (45) |
30–60 | 15 348 (41) |
60–90 | 3881 (10) |
91+ | 1544 (4) |
Great circle distance | |
Median (IQR) | 18.1 (7.1–47.9) |
Sex | |
Male | 26 833 (71) |
Female | 10 897 (29) |
Race (n = 37 311) | |
White | 32 978 (88) |
Black | 3140 (8) |
Other | 1193 (3) |
Median household income (n = 37 082) | |
<$40 227 | 7539 (20) |
$40 227–50 353 | 9010 (24) |
$50 354–63 332 | 8616 (23) |
≥$63 333 | 11 917 (32) |
Percent with no high school degree (n = 37 186) | |
≥17.6 | 7943 (21) |
10.9–17.5 | 10 210 (27) |
6.3–10.8 | 10 456 (28) |
<6.3 | 8577 (23) |
Insurance status (n = 36 570) | |
Not insured | 2042 (6) |
Private insurance | 16 464 (45) |
Public insurance | 18 064 (49) |
Urban status (n = 36 853) | |
Nonmetropolitan | 7218 (20) |
Metropolitan | 29 635 (80) |
Facility type (n = 36 651) | |
Community cancer program | 1491 (4) |
Comprehensive community cancer program | 8668 (24) |
Academic/research program | 23 110 (63) |
Integrated network cancer program | 3382 (9) |
Charlson-Deyo score | |
0 | 28 028 (74) |
1 | 7297 (19) |
2 | 1746 (5) |
3+ | 659 (2) |
Surgical margin status (n = 35 902) | |
Negative | 30 244 (84) |
Positive | 5658 (16) |
TNM pathologic stage (n = 32 394) | |
1 | 5112 (16) |
2 | 3677 (11) |
3 | 5183 (16) |
4 | 18 422 (57) |
Adjuvant treatment | |
No adjuvant treatment | 16 451 (44) |
Adjuvant radiation | 9860 (26) |
Adjuvant chemoradiation | 11 419 (30) |
Primary site | |
Oral cavity | 18 672 (49) |
Oropharynx | 10 697 (28) |
Larynx | 7641 (20) |
Hypopharynx | 720 (2) |
IQR interquartile range, TTS time to surgery; TNM tumor-node-metastasis